A New Jersey-based drugmaker announced this week that beginning in December, its 340B contract pharmacy restrictions will apply to Health [...] …
Month: October 2024
A Washington state hospital on Tuesday became the fifth provider to sue the federal government for authorizing Johnson & Johnson [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Four drugmakers are urging a federal appeals court to affirm a lower court’s decision to dismiss a California health system’s [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
An organization that describes itself as being “comprised of dozens of national, public health, patient advocacy and multicultural organizations,” but [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The growth in total 340B purchases last year was largely a result of drugmaker price increases and broader healthcare trends, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A California-based healthcare startup recently announced that it has raised more than $30 million, as part of a campaign with [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B drug discount program continued to be a hot topic for lobbyists in the third quarter of 2024, keeping [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug purchases under the 340B program reached $66.3 billion in 2023, marking a 24% increase over the $54 billion in [...] …